These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Formulation, characterization and optimization of hepatitis B surface antigen (HBsAg)-loaded chitosan microspheres for oral delivery. Premaletha K; Licy CD; Jose S; Saraladevi A; Shirwaikar A; Shirwaikar A Pharm Dev Technol; 2012; 17(2):251-8. PubMed ID: 21108582 [TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide derived alginate coated Hepatitis B antigen loaded chitosan nanoparticles for oral mucosal immunization. Saraf S; Jain S; Sahoo RN; Mallick S Int J Biol Macromol; 2020 Jul; 154():466-476. PubMed ID: 32194106 [TBL] [Abstract][Full Text] [Related]
4. N,N,N-Trimethyl chitosan nanoparticles for controlled intranasal delivery of HBV surface antigen. Subbiah R; Ramalingam P; Ramasundaram S; Kim DY; Park K; Ramasamy MK; Choi KJ Carbohydr Polym; 2012 Aug; 89(4):1289-97. PubMed ID: 24750944 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics. Tafaghodi M; Saluja V; Kersten GF; Kraan H; Slütter B; Amorij JP; Jiskoot W Vaccine; 2012 Aug; 30(36):5341-8. PubMed ID: 22749834 [TBL] [Abstract][Full Text] [Related]
6. Poly(vinyl alcohol)-coated chitosan microparticles act as an effective oral vaccine delivery system for hepatitis B vaccine in rat model. Shrestha B; Rath JP IET Nanobiotechnol; 2014 Dec; 8(4):201-7. PubMed ID: 25429498 [TBL] [Abstract][Full Text] [Related]
7. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation. Fan B; Xing Y; Zheng Y; Sun C; Liang G Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290 [TBL] [Abstract][Full Text] [Related]
8. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model. Amidi M; Romeijn SG; Verhoef JC; Junginger HE; Bungener L; Huckriede A; Crommelin DJ; Jiskoot W Vaccine; 2007 Jan; 25(1):144-53. PubMed ID: 16973248 [TBL] [Abstract][Full Text] [Related]
9. Rational design and evaluation of HBsAg polymeric nanoparticles as antigen delivery carriers. Dewangan HK; Pandey T; Maurya L; Singh S Int J Biol Macromol; 2018 May; 111():804-812. PubMed ID: 29343454 [TBL] [Abstract][Full Text] [Related]
10. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles. Borges O; Cordeiro-da-Silva A; Tavares J; Santarém N; de Sousa A; Borchard G; Junginger HE Eur J Pharm Biopharm; 2008 Jun; 69(2):405-16. PubMed ID: 18364251 [TBL] [Abstract][Full Text] [Related]
11. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation. Paliwal R; Paliwal SR; Agrawal GP; Vyas SP Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712 [TBL] [Abstract][Full Text] [Related]
12. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity. Pawar D; Mangal S; Goswami R; Jaganathan KS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265 [TBL] [Abstract][Full Text] [Related]
13. Oral immunization of mice with Omp31-loaded Abkar M; Fasihi-Ramandi M; Kooshki H; Sahebghadam Lotfi A Int J Nanomedicine; 2017; 12():8769-8778. PubMed ID: 29263667 [TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Makhlof A; Tozuka Y; Takeuchi H Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939 [TBL] [Abstract][Full Text] [Related]
15. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles. Ramalingam P; Ko YT Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233 [TBL] [Abstract][Full Text] [Related]
16. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response. Pawar D; Jaganathan KS Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494 [TBL] [Abstract][Full Text] [Related]
17. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption. Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015 [TBL] [Abstract][Full Text] [Related]
18. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes. Shukla A; Katare OP; Singh B; Vyas SP Int J Pharm; 2010 Jan; 385(1-2):47-52. PubMed ID: 19835938 [TBL] [Abstract][Full Text] [Related]
19. Assessment of Exenatide loaded Biotinylated Trimethylated Chitosan/HP- 55 Nanoparticles. Guo H; Yan X; Tang H; Zhang X Curr Drug Deliv; 2022; 19(1):32-40. PubMed ID: 34126896 [TBL] [Abstract][Full Text] [Related]
20. Chitosan-based nanoparticles for improving immunization against hepatitis B infection. Prego C; Paolicelli P; Díaz B; Vicente S; Sánchez A; González-Fernández A; Alonso MJ Vaccine; 2010 Mar; 28(14):2607-14. PubMed ID: 20096389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]